3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Motor Activity
3
Neoplasms
2
Frailty
2
Urologic Neoplasms
1
Stomach Neoplasms
1
Smoking
1
Risk Reduction Behavior
1
Postoperative Complications
1
Patient Preference
1
Obesity
1
Malnutrition
1
Hematologic Neoplasms
1
Female Reproductive Cancer
1
Esophageal Neoplasms
1
Alcohol Drinking
1
Interventions
Cyclophosphamide
6
fludarabine
5
Exercise
4
Blood Specimen Collection
4
Surveys and Questionnaires
3
Immunotherapy, Adoptive
3
thymoglobulin
2
pegylated granulocyte colony-stimulating factor
2
Voriconazole
2
Stem Cell Transplantation
2
Saline Solution
2
Physical Therapy Modalities
2
Parenteral Nutrition
2
Mycophenolic Acid
2
Etoposide
2
Cytarabine
2
CF regimen
2
BNT162 Vaccine
2
Azacitidine
2
venetoclax
1
trihexyltetradecylphosphonium chloride
1
treosulfan
1
shengxuening
1
ruxolitinib
1
ramosetron
1
monalizumab
1
glucarpidase
1
fludarabine phosphate
1
ferrous succinate
1
eltrombopag
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hematologic Neoplasms
×
Nutritional Support
×
Clear all
NCT04057443
2019-08-30
ICOSENIORHEM
L'Hospitalet de Llobregat
Phase NA
Unknown
80 enrolled